Search clinical trials for: Antidepressive Agents -- *therapeutic use

Total 200768 results

Dartmouth-Hitchcock Medical Center
University of South Carolina; University of Massachusetts, Worcester; Michigan...

Completed

Risperidone and Desipramine in Alcohol Use and Schizophrenia (RADIAUS)

Alcoholism | Schizophrenia | Dual Diagnosis

United States
Dartmouth-Hitchcock Medical Center
AstraZeneca; Augusta University

Completed

Efficacy of Quetiapine in the Treatment of Patients With Schizophrenia and a Comorbid Substance Use Disorder

Schizophrenia | Schizoaffective Disorder | Substance Abuse | Alcohol Abuse | Psychotic Disorder

United States
Phillip Coffin, MD, MIA
National Institute on Drug Abuse (NIDA)

Completed

Mirtazapine for the Treatment of Methamphetamine Dependence Among MSM (M2.0)

Amphetamine-Related Disorders

United States
Mclean Hospital
Eli Lilly and Company

Completed

An Open-Label Trial of Duloxetine for the Treatment of Irritable Bowel Syndrome

Irritable Bowel Syndrome

United States
Centre for Addiction and Mental Health
Ontario Ministry of Health and Long Term Care

Completed

Distribution of Bupropion and Varenicline to Increase Smoking Cessation Attempts

Smoking | Smoking Cessation | Tobacco Use Disorder

Canada
Boston Medical Center
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Completed

Psychosocial and Medication Treatment for Anxiety in Alcoholism

Alcohol-Related Disorders | Anxiety Disorders

United States
NYU Langone Health
National Institute on Drug Abuse (NIDA); GlaxoSmithKline

Completed

Bupropion For Reducing High-Risk Behaviors in Depressed Men Who Have Sex With Men (MSM)

Depression | HIV Infections

United States
Duke University
National Institute on Drug Abuse (NIDA)

Completed

Mechanistic Evaluations of Pre-Cessation Therapies for Smoking Cessation (ConNicBrain)

Nicotine Dependence

United States
Lisa Sanderson Cox, PhD
National Cancer Institute (NCI)

Completed

Health Education Counseling With or Without Bupropion in Helping African Americans Stop Smoking

Kidney Cancer | Cervical Cancer | Leukemia | Head and Neck Cancer | Gastric Cancer | Pancreatic Cancer | Esophageal Cancer | Tobacco Use Disorder | Lung Cancer | Bladder Cancer | Liver Cancer

United States
Jed E. Rose
National Institute on Drug Abuse (NIDA); Philip Morris USA, Inc.

Completed

Evaluation of Moclobemide, a Reversible MAO-A Inhibitor, as an Adjunct to Nicotine Replacement Therapy in Female Smokers (RIMA)

Nicotine Dependence

United States
New York State Psychiatric Institute
Eli Lilly and Company

Completed

Duloxetine for Chronic Depression: a Double-blind Study

Dysthymic Disorder | Depressive Disorder NOS

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA); Research Foundation for Mental Hygiene...

Completed

Effect of Quetiapine on Marijuana Withdrawal and Relapse

Marijuana Smoking

United States
KK Women's and Children's Hospital

Completed

Use of S+Ketamine During Target-Controlled Intravenous Anaesthesia After Abdominal Hysterectomy

Anesthesia | Ketamine | Hysterectomy | Morphine

Singapore
Vanderbilt University Medical Center

Completed

Metabolism-informed Care for Smoking Cessation

Tobacco Use | Tobacco Use Cessation
Mark Vander Weg
VA Office of Research and Development

Unknown

Dissemination of a Tailored Tobacco Quitline for Rural Veteran Smokers

Tobacco Use | Nicotine Dependence

United States
GlaxoSmithKline

Completed

Special Drug Use Investigation for PAXIL Tablet (20mg-Clinical Symptom Progression)

Mental Disorders
GlaxoSmithKline

Completed

Special Drug Use Investigation for PAXIL Tablet (Long-term)

Mental Disorders
GlaxoSmithKline

Completed

Drug Use Investigation for PAXIL Tablet

Mental Disorders
Roswell Park Cancer Institute

Completed

Bupropion in Helping Adults Stop Smoking

Kidney Cancer | Cervical Cancer | Leukemia | Head and Neck Cancer | Gastric Cancer | Pancreatic Cancer | Esophageal Cancer | Tobacco Use Disorder | Lung Cancer | Bladder Cancer | Liver Cancer

United States
GlaxoSmithKline

Completed

Carcinogenicity Study of Bupropion

Depressive Disorder | Cancer
University of Cincinnati
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Completed

Efficacy and Tolerability of Topiramate in Treatment of Bipolar Mania and Alcohol Use in Adolescents and Young Adults

Bipolar Disorder | Alcohol Abuse

United States
National Institute on Drug Abuse (NIDA)

Completed

Effectiveness of Bupropion for Treating Nicotine Dependence in Young People

Tobacco Use Disorder | Tobacco Use Cessation

United States
GlaxoSmithKline

Completed

Special Drug Use Investigation for PAXIL Tablet (Investigation in Case of Administered From 20mg/Day)

Panic Disorder
GlaxoSmithKline

Completed

Special Drug Use Investigation for PAXIL Tablet (Pediatric Panic Disorder)

Panic Disorder
The Cleveland Clinic

Terminated

Effect of Nortriptyline on Abdominal Pain/Discomfort and Quality of Life in Patients With Nonulcer Dyspepsia

Non Ulcer Dyspepsia

United States
Peking University

Unknown

Guidance Model of Standardized Treatment of Antidepressants in Bipolar Disorder

the Use of Antidepressants in Patients With Bipolar Depression

China
University of Pittsburgh
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Completed

Double-blind Pilot Trial of Mirtazapine for the Treatment of Co-occurring AD/MDD. (PT-MAD)

Major Depressive Disorder | Alcohol Use Disorder

United States
University of Pittsburgh

Completed

Treatment of Young Adults With Comorbid AUD/MDD: A Pilot Medication Trial (YAAD-P)

Major Depressive Disorder | Alcohol Use Disorder

United States
Stanford University
GlaxoSmithKline

Completed

Treatment of Nicotine Dependence and Acute Depression

Major Depressive Disorder | Nicotine Dependence

United States
Centre for Addiction and Mental Health
Ontario Ministry of Health and Long Term Care

Completed

STOP Study: Effectiveness of Zyban in a Clinical Population

Smoking Cessation | Cigarette Smoking | Nicotine Addiction

Canada
Janssen Research & Development, LLC

Completed

Crossover Study to Evaluate the Abuse Potential of Intranasal Esketamine Compared to Racemic Intravenous Ketamine in Nondependent, Recreational Drug Users

Drug Abuse

United States
Centre for Addiction and Mental Health
Global Research Awards for Nicotine Dependence (GRAND)

Completed

The MATCH (Medication Aids for Tobacco Cessation and Health) Study (MATCH)

Tobacco Use Disorder | Nicotine Dependence

Canada
National Institute on Drug Abuse (NIDA)
VA Office of Research and Development

Completed

Selegiline for Smoking Cessation - 1

Nicotine Dependence

United States
National Institute on Drug Abuse (NIDA)
Research Foundation for Mental Hygiene, Inc.

Completed

Maintenance Treatment for Abstinent Smokers

Tobacco Use Disorder

United States
National Institute on Drug Abuse (NIDA)

Completed

Effect of Bupropion on Smoking Behavior in Smokers With Schizophrenia

Schizophrenia | Tobacco Use Disorder

United States
National Institute on Drug Abuse (NIDA)

Completed

Treating Nicotine Dependence in Schizophrenic Individuals: Effectiveness of Bupropion - 1

Schizophrenia | Tobacco Use Disorder | Tobacco Use Cessation
National Institute on Drug Abuse (NIDA)

Completed

Effectiveness of Selegiline in Treating Marijuana Dependent Individuals - 1

Marijuana Abuse

United States
National Institute on Drug Abuse (NIDA)

Completed

Maintaining Abstinence in Chronic Cigarette Smokers - 1

Tobacco Use Disorder

United States
National Institute on Drug Abuse (NIDA)

Completed

Impact of Smoking Cessation on Sleep - 5

Tobacco Use Cessation | Sleep Disorders

United States
National Institute on Drug Abuse (NIDA)

Completed

Fluoxetine to Reduce Cocaine Use in Cocaine and Opioid Addicts

Opioid-Related Disorders | Cocaine-Related Disorders

United States
National Institute on Drug Abuse (NIDA)

Completed

Safety and Effectiveness of Sustained Release Bupropion in Treating Individuals With Schizophrenia Who Smoke

Psychotic Disorders | Schizophrenia | Tobacco-Use Disorder

United States
University Hospitals Cleveland Medical Center
National Alliance for Research on Schizophrenia and Depression; AstraZeneca

Completed

Quetiapine Extended Release (XR) in Bipolar Patients With Comorbid Generalized Anxiety Disorder (GAD)

Anxiety Disorders | Anxiety | Bipolar Disorder | Substance Use Disorders

United States
University of Wisconsin, Madison
National Institutes of Health (NIH)

Completed

Bupropion Alone or Combined With Nicotine Gum

Tobacco Dependence

United States
Kyoto University
National Center of Neurology and Psychiatry, Japan

Completed

Strategic Use of New Generation Antidepressants for Depression (SUN(^_^)D)

Unipolar Major Depressive Episode

Japan
North Suffolk Mental Health Association

Completed

Smoking Relapse Prevention in Schizophrenia

Schizophrenia | Schizoaffective Disorder | Smokers

United States
National Institute on Drug Abuse (NIDA)

Terminated

Efficacy and Safety of Bupropion for Treatment of Adolescent Smoking

Tobacco Dependence

United States
Stanford University
National Institute on Drug Abuse (NIDA)

Completed

Selegiline Patch for Treatment of Nicotine Dependence

Tobacco Use Disorder

United States
University of Pittsburgh
National Institute on Drug Abuse (NIDA)

Completed

Bupropion and Weight Control for Smoking Cessation - 1

Tobacco Use Disorder

United States
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Completed

Comparison of Nicotine Inhaler and/or Bupropion in Helping People to Stop Smoking and Prevent the Recurrence of Smoking

Lung Cancer

United States, Canada
Cairo University

Unknown

Does Adding Oral Contraceptives to Fluoxetine Improve the Management of Premenstrual Syndrome?

Premenstrual Syndrome

Egypt

Search clinical trials for: Antidepressive Agents -- *therapeutic use

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Moldova

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations